Annaida Technologies
About:
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance.
Website: http://www.annaida.ch
Top Investors: Venture Kick, Zürcher Kantonal Bank, EASME - EU Executive Agency for SMEs, Hemex, MassChallenge
Description:
Annaida Technologies has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance (“µNMR”) at a scale 10-fold better than existing technologies.
Total Funding Amount:
$1.49M
Headquarters Location:
Lausanne, Vaud, Switzerland
Founded Date:
2018-01-01
Founders:
Gaurasundar Marc Conley Gaurasundar Marc Conley, Marco Grisi
Number of Employees:
11-50
Last Funding Date:
2020-04-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai